ASBP

Conviction 80HealthcareScan · Mon, Jul 20, 2026

ASBP$6.39+2.40%

ResistanceSupportVol 14

Vol MA14 70.17K

Apr 20May 6May 26Jun 11Jul 1Jul 20

Aspire Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.aspirebiolabs.com ↗

Price6.39

Change+2.40%

Gap+1.44%

Rel volume0.20×

Avg volume69.92K

Avg $ vol415.05K

SMA 206.07

SMA 505.65

SMA 2001.90

Price vs 50+13.06%

Price vs 200+236.40%

MA stackbullish

50/200 cross—

Supertrendup · 4.74

RSI (14)58

MACD hist-0.02

MACD cross—

Stoch %K / %D92 / 87

ADX (14)14

+DI / −DI20 / 18

RSI divergence—

MACD divergence—

ATR %+9.43%

ADR %9.51%

52w high6.68

52w low0.0519

From 52w high-4.34%

Above 52w low+12212.14%

New 52w highNo

SqueezeOn · 22d

Bollinger width18.40%

%B0.79

Donchian pos89.59%

Donchian high6.60

Donchian low4.58

AVWAP (52w high)5.61

vs AVWAP high+14.00%

AVWAP (52w low)0.4239

vs AVWAP low+1407.46%

OBV trendDown

Chaikin MF (20)0.08

Today vs 20d0.20×

Avg vol (14d)70.17K

Avg vol (20d)69.92K

Avg $ vol (20d)415.05K

Market cap8.28M

RS 3m (vs SPY)+1974.07%

RS 6m (vs SPY)+10522.66%

RS line new highNo

Trend template8/8

Technical rank86.7

1 week+7.04%

1 month+0.47%

3 months+2269.30%

6 months+12212.14%

1 year+1694.94%

YTD+4567.64%

P/E-0.34

P/B2.14

P/S—

P/FCF—

EPS-16.38

Div yield—

ROE-632.83%

ROA-343.97%

Debt/Eq—

Current2.26

EV/EBITDA—

Gross margin-1.87%

Net margin—

Rev growth—

EPS growth-1768.95%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.42M

Revenue28.35K

Net income-3.22M

Gross profit5.75K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.3M

Employees—

ListedThu, Feb 20, 2025

Free float4.51M

Float %89.7%

Short interest101.41K

Days to cover0.6d

Short volume68.1%

Squeeze score26 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank86.7 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.95

Support4.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ASBP

All disclosures →

No recent disclosed trades by Congress in ASBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASBP

No recent insider (Form 4) filings in ASBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ASBP · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.